Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the efficacy, and safety of HR091506 tablets for
treatment of gout with hyperuricemia in adults, and to compare the results with febuxostat
tablets in the same doses.